This company listing is no longer active
This company may still be operating, however this listing is no longer active. Find out why through their latest events.
このページの翻訳は実験的なもので、現在 開発中です。お待ちしております！
ACGN 株式概要
Aceragen, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for rare pulmonary and rheumatic diseases in the United States.
Aceragen, Inc. 競合他社
価格と性能
| 過去の株価 | |
|---|---|
| 現在の株価 | US$0.38 |
| 52週高値 | US$16.00 |
| 52週安値 | US$0.36 |
| ベータ | 1.14 |
| 11ヶ月の変化 | -48.99% |
| 3ヶ月変化 | -76.54% |
| 1年変化 | -95.55% |
| 33年間の変化 | -98.96% |
| 5年間の変化 | -99.78% |
| IPOからの変化 | -100.00% |
最新ニュース
Recent updates
Idera Pharmaceuticals completes acquisition of Aceragen
Sep 28We're Keeping An Eye On Idera Pharmaceuticals' (NASDAQ:IDRA) Cash Burn Rate
Aug 24
We Think Idera Pharmaceuticals (NASDAQ:IDRA) Needs To Drive Business Growth Carefully
May 11Is Idera Pharmaceuticals (NASDAQ:IDRA) In A Good Position To Deliver On Growth Plans?
Mar 07When Will Idera Pharmaceuticals, Inc. (NASDAQ:IDRA) Become Profitable?
Jan 31Idera outlines capital requirement to move tilsotolimod toward commercialization in advanced melanoma
Jan 13Could The Idera Pharmaceuticals, Inc. (NASDAQ:IDRA) Ownership Structure Tell Us Something Useful?
Dec 27Don't Ignore The Fact That This Insider Just Sold Some Shares In Idera Pharmaceuticals, Inc. (NASDAQ:IDRA)
Dec 27Idera Pharmaceuticals receives $5M in additional proceeds from private placement
Dec 15We're Keeping An Eye On Idera Pharmaceuticals' (NASDAQ:IDRA) Cash Burn Rate
Nov 25Idera Pharma names new operations chief
Nov 17Idera Pharmaceuticals EPS misses by $0.37
Oct 29株主還元
| ACGN | US Biotechs | US 市場 | |
|---|---|---|---|
| 7D | -11.6% | -1.9% | 0.5% |
| 1Y | -95.5% | 10.4% | 20.5% |
業界別リターン: ACGN underperformed the US Biotechs industry which returned 6.3% over the past year.
リターン対市場: ACGN underperformed the US Market which returned 4.2% over the past year.
価格変動
| ACGN volatility | |
|---|---|
| ACGN Average Weekly Movement | 23.7% |
| Biotechs Industry Average Movement | 10.3% |
| Market Average Movement | 5.7% |
| 10% most volatile stocks in US Market | 15.2% |
| 10% least volatile stocks in US Market | 2.8% |
安定した株価: ACGN's share price has been volatile over the past 3 months.
時間の経過による変動: ACGN's weekly volatility (24%) has been stable over the past year, but is still higher than 75% of US stocks.
会社概要
| 設立 | 従業員 | CEO（最高経営責任者 | ウェブサイト |
|---|---|---|---|
| 1989 | 26 | John Taylor | www.aceragen.com |
Aceragen, Inc. 基礎のまとめ
| ACGN 基礎統計学 | |
|---|---|
| 時価総額 | US$3.20m |
| 収益（TTM） | -US$41.05m |
| 売上高(TTM) | US$7.33m |
0.4x
P/Sレシオ-0.1x
PER（株価収益率ACGN は割高か？
公正価値と評価分析を参照収益と収入
| ACGN 損益計算書（TTM） | |
|---|---|
| 収益 | US$7.33m |
| 売上原価 | US$15.40m |
| 売上総利益 | -US$8.06m |
| その他の費用 | US$32.98m |
| 収益 | -US$41.05m |
直近の収益報告
Mar 31, 2023
次回決算日
該当なし
| 一株当たり利益（EPS） | -4.88 |
| グロス・マージン | -110.00% |
| 純利益率 | -559.86% |
| 有利子負債／自己資本比率 | 1.3% |
ACGN の長期的なパフォーマンスは？
過去の実績と比較を見る